Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-06 Sale |
2025-01-07 8:14 pm |
KALA BIO Inc. | KALA | Bazemore Todd SEE REMARKS |
1,993 | $7.63 | $15,207 | 136,348 (Indirect Direct) |
View |
| 2024-06-26 Sale |
2024-06-27 8:00 pm |
KALA BIO Inc. | KALA | Bazemore Todd SEE REMARKS |
4,653 | $4.75 | $22,102 | 83,041 (Indirect Direct) |
View |
| 2024-05-31 Sale |
2024-06-03 8:00 pm |
KALA BIO Inc. | KALA | Bazemore Todd SEE REMARKS |
2,093 | $6.09 | $12,746 | 87,694 (Indirect Direct) |
View |
| 2024-01-04 Sale |
2024-01-05 4:03 pm |
KALA BIO Inc. | KALA | Bazemore Todd SEE REMARKS |
1,405 | $6.74 | $9,470 | 119,087 (Indirect Direct) |
View |
| 2023-01-04 Sale |
2023-01-06 8:00 pm |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS |
62 | $28.54 | $1,769 | 14,836 (Indirect Direct) |
View |
| 2022-10-26 Sale |
2022-10-28 4:15 pm |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS |
214 | $6.51 | $1,393 | 2,098 (Indirect Direct) |
View |
| 2022-06-27 Sale |
2022-06-29 8:10 pm |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS |
3,092 | $0.37 | $1,144 | 115,541 (Indirect Direct) |
View |
| 2022-01-04 Sale |
2022-01-05 8:00 pm |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS |
3,454 | $1.3 | $4,490 | 356,633 (Indirect Direct) |
View |
| 2021-10-26 Sale |
2021-10-28 8:03 pm |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd CHIEF OPERATING OFFICER |
12,544 | $1.8 | $22,579 | 122,087 (Indirect Direct) |
View |
| 2021-06-28 Sale |
2021-06-29 5:25 pm |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd CHIEF OPERATING OFFICER |
2,911 | $5.77 | $16,796 | 134,631 (Indirect Direct) |
View |
| 2020-06-05 Purchase |
2020-10-28 8:36 pm |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd Chief Operating Officer |
42 | $7.8757 | $331 | 110,042 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-07 Option Award |
2025-03-10 8:00 pm |
N/A 2035-03-06 |
KALA BIO Inc. | KALA | Bazemore Todd SEE REMARKS |
45,200 | $0 | 45,200 (Direct) |
View |
| 2025-01-06 Option Award |
2025-01-07 8:14 pm |
N/A 2035-01-05 |
KALA BIO Inc. | KALA | Bazemore Todd SEE REMARKS |
55,300 | $0 | 136,348 (Direct) |
View |
| 2024-01-04 Option Award |
2024-01-05 4:03 pm |
N/A 2034-01-03 |
KALA BIO Inc. | KALA | Bazemore Todd SEE REMARKS |
35,800 | $0 | 119,087 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-23 8:00 pm |
N/A 2033-06-21 |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS |
113,629 | $0 | 149,623 (Direct) |
View |
| 2023-05-31 Option Award |
2023-06-02 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS |
21,158 | $0 | 35,994 (Direct) |
View |
| 2023-03-14 Option Award |
2023-03-15 8:00 pm |
N/A 2032-01-03 |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS |
576 | $0 | 576 (Direct) |
View |
| 2023-01-26 Option Award |
2023-01-30 4:05 pm |
N/A 2033-01-26 |
Pulmatrix Inc. | PULM | Bazemore Todd Director |
1,700 | $0 | 1,700 (Direct) |
View |
| 2023-01-04 Option Award |
2023-01-06 8:00 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS |
12,800 | $0 | 14,836 (Direct) |
View |
| 2022-01-27 Option Award |
2022-01-28 8:44 pm |
N/A 2032-01-27 |
Pulmatrix Inc. | PULM | Bazemore Todd Director |
22,100 | $0 | 22,100 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 8:00 pm |
N/A 2032-01-03 |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd SEE REMARKS |
238,000 | $0 | 356,633 (Direct) |
View |
| 2021-01-28 Option Award |
2021-02-01 9:45 pm |
N/A 2031-01-28 |
Pulmatrix Inc. | PULM | Bazemore Todd Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-05 4:53 pm |
N/A 2031-01-03 |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd Chief Operating Officer |
137,500 | $0 | 247,542 (Direct) |
View |
| 2020-10-26 Option Award |
2020-10-28 8:36 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd Chief Operating Officer |
81,000 | $0 | 110,042 (Direct) |
View |
| 2020-10-01 Option Award |
2020-10-02 4:15 pm |
N/A 2030-10-01 |
Pulmatrix Inc. | PULM | Bazemore Todd Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2020-06-25 Option Award |
2020-06-29 9:25 pm |
N/A N/A |
Kala Pharmaceuticals Inc. | KALA | Bazemore Todd Chief Operating Officer |
19,000 | $0 | 29,000 (Direct) |
View |